SCHEMBL7985071

SCHEMBL7985071

CCCCc1cc(CCCC)cc(-c2nc(O)c3c(ncn3Cc3ccccc3)n2)c1

nearest known ligand 0.39

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
BCL2L2 Q92843 1/20 0.39
HPGD P15428 1/20 0.38
SMN1; SMN2 Q16637 4/20 0.38
ALDH1A1 P00352 2/20 0.38
GAA P10253 1/20 0.38
AGTR1 P30556 3/20 0.37
AGTR2 P50052 3/20 0.37
PDE4A P27815 1/20 0.35
PDE4B Q07343 1/20 0.35
PDE4C Q08493 1/20 0.35
PDE4D Q08499 1/20 0.35
KMT2A Q03164 1/20 0.35
ADORA2B P29275 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7985325 0.84 HPGD (0.42) HPGDSMN1; SMN2ALDH1A1GAAKMT2A
SCHEMBL7988787 0.83 SMN1; SMN2 (0.42) HPGDSMN1; SMN2ALDH1A1GAAKMT2A
SCHEMBL7987771 0.83 SMN1; SMN2 (0.43) HPGDSMN1; SMN2ALDH1A1GAAKMT2A
SCHEMBL7975267 0.83 SMN1; SMN2 (0.46) HPGDSMN1; SMN2ALDH1A1GAAKMT2A
SCHEMBL7984888 0.82 HPGD (0.41) HPGDSMN1; SMN2ALDH1A1GAAKMT2A
SCHEMBL7987609 0.82 PDE4A (0.43) HPGDSMN1; SMN2ALDH1A1GAAAGTR1
SCHEMBL7985395 0.82 GAA (0.43) BCL2L2HPGDSMN1; SMN2GAALMNA
SCHEMBL7985348 0.81 GAA (0.53) HPGDSMN1; SMN2ALDH1A1GAARXFP1
SCHEMBL8056959 0.81 NR1H4 (0.39) HPGDSMN1; SMN2ALDH1A1GAAKMT2A
SCHEMBL7984454 0.80 GAA (0.42) GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed